GlassScriptPhysician profile
Corey Deberry-Seguine
NPI 1669921524
$6,983.25
in general payments reported to CMS, 2019-2025
43 companies · $2,215 in 2025
The $2,215 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,380 · 2022: $546 · 2023: $1,372 · 2024: $1,471 · 2025: $2,215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,582 · Consulting Fee: $265 · Education: $211.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,581.84 |
| Consulting Fee | $265.39 |
| Education | $210.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $908.81 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $716.45 | 2021-2025 | Cuvitru, Hyqvia, Takhzyro |
| Regeneron Healthcare Solutions, INC. | $661.84 | 2023-2025 | Dupixent |
| Astrazeneca Pharmaceuticals LP | $647.38 | 2021-2025 | Tezspire, Airsupra, Breztri |
| Abbvie INC. | $379.35 | 2021-2025 | |
| Csl Behring | $360.23 | 2023-2025 | Hizentra, Haegarda, Privigen |
| Grifols USA, LLC | $347.08 | 2023-2025 | Xembify |
| Genzyme Corporation | $337.66 | 2023-2025 | |
| Glaxosmithkline, LLC. | $324.16 | 2023-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Adma Biomanufacturing LLC | $265.39 | 2023-2025 | |
| Genentech USA, INC. | $213.57 | 2021-2024 | Xolair |
| Incyte Corporation | $196.20 | 2023-2025 | Opzelura |
| Leo Pharma INC. | $136.23 | 2023-2025 | Adbry, Anzupgo |
| Blueprint Medicines Corporation | $125.34 | 2023-2024 | Ayvakit |
| Kaleo, INC. | $103.51 | 2023-2024 | Auvi-Q |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corey Deberry-Seguine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.